Table of Contents

1 RESEARCH SCOPE

• 1.1 Research Product Definition
• 1.2 Research Segmentation
  • 1.2.1 Product Type
  • 1.2.2 Main product Type of Major Players
• 1.3 Demand Overview
• 1.4 Research Methodology

2 GLOBAL PULMONARY EDEMA TREATMENT INDUSTRY

• 2.1 Summary about Pulmonary Edema Treatment Industry
• 2.2 Pulmonary Edema Treatment Market Trends
  • 2.2.1 Pulmonary Edema Treatment Production & Consumption Trends
  • 2.2.2 Pulmonary Edema Treatment Demand Structure Trends
• 2.3 Pulmonary Edema Treatment Cost & Price

3 MARKET DYNAMICS

• 3.1 Manufacturing & Purchasing Behavior in 2020
• 3.2 Market Development under the Impact of COVID-19
  • 3.2.1 Drivers
  • 3.2.2 Restraints
  • 3.2.3 Opportunity
  • 3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

• 4.1 Region Segmentation (2017 to 2021f)
  • 4.1.1 North America (U.S., Canada and Mexico)
  • 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  • 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  • 4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  • 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
• 4.2 Product Type Segmentation (2017 to 2021f)
  • 4.2.1 Diagnosis
  • 4.2.2 Treatment
• 4.3 Consumption Segmentation (2017 to 2021f)
  • 4.3.1 Hospitals and Clinics
  • 4.3.2 Academic Institutes
  • 4.3.3 Retail Pharmacies
  • 4.3.4 Household
  • 4.3.5 Others

5 NORTH AMERICA MARKET SEGMENT

• 5.1 Region Segmentation (2017 to 2021f)
  • 5.1.1 U.S.
  • 5.1.2 Canada
  • 5.1.3 Mexico
• 5.2 Product Type Segmentation (2017 to 2021f)
  • 5.2.1 Diagnosis
  • 5.2.2 Treatment
• 5.3 Consumption Segmentation (2017 to 2021f)
  • 5.3.1 Hospitals and Clinics
  • 5.3.2 Academic Institutes
  • 5.3.3 Retail Pharmacies
  • 5.3.4 Household
  • 5.3.5 Others
• 5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

• 6.1 Region Segmentation (2017 to 2021f)
  • 6.1.1 Germany
  • 6.1.2 UK
  • 6.1.3 France
  • 6.1.4 Italy
  • 6.1.5 Rest of Europe
• 6.2 Product Type Segmentation (2017 to 2021f)
  • 6.2.1 Diagnosis
  • 6.2.2 Treatment
• 6.3 Consumption Segmentation (2017 to 2021f)
  • 6.3.1 Hospitals and Clinics
  • 6.3.2 Academic Institutes
  • 6.3.3 Retail Pharmacies
  • 6.3.4 Household
  • 6.3.5 Others
• 6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

• 7.1 Region Segmentation (2017 to 2021f)
  • 7.1.1 China
  • 7.1.2 India
  • 7.1.3 Japan
  • 7.1.4 South Korea
  • 7.1.5 Southeast Asia
  • 7.1.6 Australia
  • 7.1.7 Rest of Asia Pacific
• 7.2 Product Type Segmentation (2017 to 2021f)
  • 7.2.1 Diagnosis
  • 7.2.2 Treatment
• 7.3 Consumption Segmentation (2017 to 2021f)
  • 7.3.1 Hospitals and Clinics
  • 7.3.2 Academic Institutes
  • 7.3.3 Retail Pharmacies
  • 7.3.4 Household
  • 7.3.5 Others
• 7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

• 8.1 Region Segmentation (2017 to 2021f)
  • 8.1.1 Brazil
  • 8.1.2 Argentina
  • 8.1.3 Rest of Latin America
• 8.2 Product Type Segmentation (2017 to 2021f)
  • 8.2.1 Diagnosis
  • 8.2.2 Treatment
• 8.3 Consumption Segmentation (2017 to 2021f)
  • 8.3.1 Hospitals and Clinics
  • 8.3.2 Academic Institutes
  • 8.3.3 Retail Pharmacies
  • 8.3.4 Household
  • 8.3.5 Others
• 8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

• 9.1 Region Segmentation (2017 to 2021f)
  • 9.1.1 GCC
  • 9.1.2 North Africa
  • 9.1.3 South Africa
  • 9.1.4 Rest of Middle East and Africa
• 9.2 Product Type Segmentation (2017 to 2021f)
  • 9.2.1 Diagnosis
  • 9.2.2 Treatment
• 9.3 Consumption Segmentation (2017 to 2021f)
  • 9.3.1 Hospitals and Clinics
  • 9.3.2 Academic Institutes
  • 9.3.3 Retail Pharmacies
  • 9.3.4 Household
  • 9.3.5 Others
• 9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

• 10.1 Brief Introduction of Major Players
  • 10.1.1 Pfizer Inc (US)
  • 10.1.2 ARGON MEDICAL (US)
  • 10.1.3 Edwards Lifesciences Corporation (US)
  • 10.1.4 BD (US)
  • 10.1.5 Alcaliber S.A. (Spain)
  • 10.1.6 Lupin Pharmaceuticals (India)
  • 10.1.7 Vitaltec Corporation (China)
  • 10.1.8 Medtronic (US)
  • 10.1.9 Koninklijke Philips N.V. (The Netherlands)
  • 10.1.10 Siemens Healthcare (Germany)
  • 10.1.11 Hitachi Medical Corporation (US)
  • 10.1.12 Canon Medical Systems Corporation (Japan)
• 10.2 Pulmonary Edema Treatment Sales Date of Major Players (2017-2020e)
  • 10.2.1 Pfizer Inc (US)
  • 10.2.2 ARGON MEDICAL (US)
  • 10.2.3 Edwards Lifesciences Corporation (US)
  • 10.2.4 BD (US)
  • 10.2.5 Alcaliber S.A. (Spain)
  • 10.2.6 Lupin Pharmaceuticals (India)
  • 10.2.7 Vitaltec Corporation (China)
  • 10.2.8 Medtronic (US)
  • 10.2.9 Koninklijke Philips N.V. (The Netherlands)
  • 10.2.10 Siemens Healthcare (Germany)
  • 10.2.11 Hitachi Medical Corporation (US)
  • 10.2.12 Canon Medical Systems Corporation (Japan)
• 10.3 Market Distribution of Major Players
• 10.4 Global Competition Segmentation

11 MARKET FORECAST

• 11.1 Forecast by Region
• 11.2 Forecast by Demand
• 11.3 Environment Forecast
  • 11.3.1 Impact of COVID-19
  • 11.3.2 Geopolitics Overview
  • 11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

List of Table

1.Table Pulmonary Edema Treatment Product Type Overview

2.Table Pulmonary Edema Treatment Product Type Market Share List

3.Table Pulmonary Edema Treatment Product Type of Major Players

4.Table Brief Introduction of Pfizer Inc (US)

5.Table Brief Introduction of ARGON MEDICAL (US)

6.Table Brief Introduction of Edwards Lifesciences Corporation (US)

7.Table Brief Introduction of BD (US)

8.Table Brief Introduction of Alcaliber S.A. (Spain)

9.Table Brief Introduction of Lupin Pharmaceuticals (India)

10.Table Brief Introduction of Vitaltec Corporation (China)

11.Table Brief Introduction of Medtronic (US)

12.Table Brief Introduction of Koninklijke Philips N.V. (The Netherlands)

13.Table Brief Introduction of Siemens Healthcare (Germany)

14.Table Brief Introduction of Hitachi Medical Corporation (US)

15.Table Brief Introduction of Canon Medical Systems Corporation (Japan)

16.Table Products & Services of Pfizer Inc (US)

17.Table Products & Services of ARGON MEDICAL (US)

18.Table Products & Services of Edwards Lifesciences Corporation (US)

19.Table Products & Services of BD (US)

20.Table Products & Services of Alcaliber S.A. (Spain)

21.Table Products & Services of Lupin Pharmaceuticals (India)

22.Table Products & Services of Vitaltec Corporation (China)

23.Table Products & Services of Medtronic (US)

24.Table Products & Services of Koninklijke Philips N.V. (The Netherlands)

25.Table Products & Services of Siemens Healthcare (Germany)

26.Table Products & Services of Hitachi Medical Corporation (US)

27.Table Products & Services of Canon Medical Systems Corporation (Japan)

28.Table Market Distribution of Major Players

29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

31.Table Global Pulmonary Edema Treatment Market Forecast (Million USD) by Region 2021f-2026f

32.Table Global Pulmonary Edema Treatment Market Forecast (Million USD) Share by Region 2021f-2026f

33.Table Global Pulmonary Edema Treatment Market Forecast (Million USD) by Demand 2021f-2026f

34.Table Global Pulmonary Edema Treatment Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure

1.Figure Global Pulmonary Edema Treatment Market Size under the Impact of COVID-19, 2017-2021f (USD Million)

2.Figure Global Pulmonary Edema Treatment Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)

3.Figure Global Pulmonary Edema Treatment Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)

4.Figure Global Pulmonary Edema Treatment Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)

5.Figure Global Pulmonary Edema Treatment Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)

6.Figure Global Pulmonary Edema Treatment Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)

7.Figure Global Pulmonary Edema Treatment Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)

8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

13.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

14.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

15.Figure Hospitals and Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

16.Figure Academic Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

17.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

18.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

19.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

20.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

21.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

22.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

23.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

24.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

25.Figure Hospitals and Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

26.Figure Academic Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

27.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

28.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

30.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

31.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

32.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

33.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

34.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

35.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

36.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

37.Figure Hospitals and Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

38.Figure Academic Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

39.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

40.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

41.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

42.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

43.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

44.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

45.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

46.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

47.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

48.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

49.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

50.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

51.Figure Hospitals and Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

52.Figure Academic Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

53.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

54.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

56.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

57.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

58.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

59.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

60.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

61.Figure Hospitals and Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

62.Figure Academic Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

63.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

64.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

65.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

66.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

67.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

68.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

69.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

70.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

71.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

72.Figure Hospitals and Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

73.Figure Academic Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

74.Figure Retail Pharmacies Segmentation Market Size (USD Million

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Pulmonary Edema Treatment market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Pulmonary Edema Treatment market segmented into
Diagnosis
Treatment

Based on the end-use, the global Pulmonary Edema Treatment market classified into
Hospitals and Clinics
Academic Institutes
Retail Pharmacies
Household
Others

Based on geography, the global Pulmonary Edema Treatment market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Pfizer Inc (US)
ARGON MEDICAL (US)
Edwards Lifesciences Corporation (US)
BD (US)
Alcaliber S.A. (Spain)
Lupin Pharmaceuticals (India)
Vitaltec Corporation (China)
Medtronic (US)
Koninklijke Philips N.V. (The Netherlands)
Siemens Healthcare (Germany)
Hitachi Medical Corporation (US)
Canon Medical Systems Corporation (Japan)